Part A - Superfast 47140

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.

2.2 Label elements

Labelling

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

4,4'-Methylenediphenyl diisocyanate, oligomers, Triethoxy(3-isocyanatopropyl)silane, 4,4'- Methylenediphenyl diisocyanate

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P201 - Obtain special instructions before use. P260 - Do not breathe vapours. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor.

Other hazards which do not result in classification

This product contains isocyanates. Persons previously sensitized to isocyanates may develop a cross-sensitization reaction to other isocyanates. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605